Reports

Drug name	NICE TAs	Comments
Temsirolimus infusion (Torisel®)	TA207 - Temsirolimus for the treatment of relapsed or refractory mantle cell lymphoma (terminated appraisal) (Negative TA) TA178 - Bevacizumab (first-line), sorafenib (first- and second-line), sunitinib (second-line) and temsirolimus (first-line) for the treatment of advanced and/or metastatic renal cell carcinoma (Negative TA)	Hospital use only
Tenecteplase injection	TA52 - Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction	Hospital use only
Terbutaline
Teriflunomide	TA303 - Teriflunomide for treating relapsing–remitting multiple sclerosis
Teriparatide injection	TA161 - Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women
Terlipressin injection		Hospital use only
Testosterone implant		Hospital only - menopausal clinic
Tetanus immunoglobulin 250units injection
Tetracaine hydrochloride Minims® amethocaine hydrochloride		For hospital use only
Tetracosactide injection

University Hospitals Birmingham NHS Foundation Trust